Robotic Angiography System Market Synopsis

Robotic Angiography System Market Size Was Valued at USD 679.67 Million in 2023, and is Projected to Reach USD 1084.28 Million by 2030, Growing at a CAGR of 6.9% From 2024-2030.

Robotic angiography systems are medical devices used in interventional cardiology procedures, such as angiography, angioplasty, and stent placement. They integrate robotic technology with traditional angiography systems, providing greater precision and control. These systems consist of robotic arms equipped with advanced imaging technology, such as fluoroscopy and 3D angiography. Physicians control these systems from a workstation, enabling precise positioning of catheters and devices, reducing radiation exposure, improving ergonomics, and standardizing procedural techniques.

• Robotic angiography systems are used in interventional cardiology for coronary angiography, angioplasty, stent placement, peripheral angiography, complex lesion navigation, mitral valve repair, and pediatric interventions. They provide precise control over catheter movement, allowing for accurate assessment of vessel anatomy and detection of blockages or narrowing. Robotic angiography system also aid in percutaneous coronary intervention (PCI) procedures, enabling optimal positioning of balloons and stents.
• Robotic systems also excel in navigating through tortuous or calcified vessels, improving procedural success rates. Some systems are designed for transcatheter mitral valve repair or replacement procedures. Robotic angiography systems are particularly beneficial in pediatric interventions due to their smaller size and complexity. Robotic angiography systems are in high demand due to their precision, accuracy, enhanced control, reduced radiation exposure, improved ergonomics, standardization of techniques, and expansion of treatment options.
• Robotic angiography systems offer superior positioning of catheters and devices, leading to better stent placement and reduced complications. They also provide physicians with finer control over catheter movements, guidewire manipulation, and device delivery, enhancing the success rates of procedures. Robotic systems also minimize radiation exposure, reducing the need for fluoroscopic imaging. Robotic angiography systems also offer improved ergonomics, standardizing techniques across different operators, and expanding treatment options. Healthcare institutions investing in robotic angiography systems may gain a competitive advantage by offering advanced cardiac care.

Robotic Angiography System Market Trend Analysis

Reduced radiation exposure for patients and medical staff

• Robotic angiography systems are being adopted in interventional cardiology due to their focus on reducing radiation exposure for patients and medical staff. Traditional angiography procedures often involve fluoroscopic imaging, which exposes both patients and staff to ionizing radiation. This was followed by a pivotal study in 164 patients that showed a 95.2% reduction of radiation to the operator.
• Robotic angiography systems optimize imaging techniques, allowing for more efficient use of fluoroscopy and minimizing exposure duration. They also offer precise control, enabling physicians to perform procedures with greater accuracy and efficiency. Remote control consoles allow physicians to operate the robotic arms from a distance, minimizing direct exposure to radiation and reducing operator fatigue.
• Automated radiation dose management features monitor radiation exposure in real time, ensuring optimal image quality while minimizing radiation dosage. Staff training and education modules promote radiation safety practices among medical staff. Radiation shielding measures and real-time radiation monitoring devices are also used to protect staff and patients from scattered radiation.

Restraints

Expensive To Acquire And Maintain, Which May Limit Their Adoption

• Robotic angiography systems are a promising technology, but their adoption is hindered by the high cost of acquisition and maintenance. The initial investment for the system, which includes purchase, installation, and setup, is substantial due to advanced technology and precision engineering. This can be prohibitive for smaller healthcare facilities with limited financial resources. The ongoing maintenance expenses, including calibration, software updates, and consumable replacement, can increase operational costs over time.
• Furthermore, specialized training and education for healthcare professionals operating robotic angiography systems can be costly, with additional fees for instructor-led courses, simulation training, and certification programs. The reimbursement landscape may not fully align with the high costs, making it difficult for healthcare providers to achieve a favorable return on investment. Moreover, smaller healthcare facilities may have limited financial resources and budget constraints, making it difficult to justify the expense of investing in robotic angiography systems.

Opportunity

Advancements in technology and increasing emphasis on patient safety

• Advancements in technology and patient safety in healthcare are significantly impacting interventional cardiology and the use of robotic angiography systems. The advancements offer enhanced precision and accuracy in procedures like angiography and angioplasty, reducing the risk of errors and complications. robotic angiography systems also improve imaging capabilities, such as high-resolution fluoroscopy and 3D angiography, allowing clinicians to better plan and execute procedures.
• Modern robotic angiography systems minimize radiation exposure for patients and healthcare providers through the optimization of imaging protocols, real-time dose monitoring, and dose-reduction algorithms. Safety features, such as collision detection algorithms and emergency stop mechanisms, mitigate potential risks during procedures.
• Standardization of procedures across different operators and healthcare institutions is also achieved through predefined protocols, automated workflows, and guided instrument navigation. Emerging technologies enable remote monitoring of patients undergoing interventional procedures, allowing clinicians to closely monitor vital signs and procedural progress in real time. The advancements contribute to patient safety by enabling proactive management of complications and rapid response to clinical events during procedures.

Challenges

Healthcare professionals require specialized training and education to operate robotic angiography systems

• The implementation of robotic angiography systems in healthcare is a complex task that requires specialized training and education. The technology involves advanced imaging systems, requiring a deep understanding of robotic control, imaging interpretation, and procedural workflow. Hands-on training involves practical experience with the equipment in simulated or clinical settings, allowing clinicians to develop proficiency and confidence in using the technology safely. Multidisciplinary collaboration is crucial, as robotic angiography systems are used in various clinical specialties.
• Training programs should foster continuous education and proficiency maintenance to ensure high-quality patient care. Resource allocation is crucial, as healthcare institutions must allocate resources for training infrastructure, instructor support, and staff education. Establishing standardized certification and credentialing processes for healthcare professionals proficient in robotic-assisted interventions is essential for ensuring competency and patient safety. Collaboration between professional societies, regulatory bodies, and healthcare institutions is necessary for the development and implementation of these programs.

Robotic Angiography System Market Segment Analysis:

Robotic Angiography System Market Segmented based on type, application, indication, and end-users.

By Type, MR Angiography Systems segment is expected to dominate the market during the forecast period

• MR angiography systems are expected to dominate in non-invasive imaging and specialized procedures due to their non-invasive nature, soft tissue visualization, and advancements in MR technology. These factors make them a preferred imaging modality for patients with radiation safety concerns, such as pediatric patients or those undergoing repeated imaging studies.
• MR angiography also offers detailed visualization of vascular structures without contrast agents, making it ideal for evaluating complex anatomical regions or patients with renal insufficiency or contrast allergies. Advancements in MR technology, such as higher field strengths and faster imaging sequences, have enhanced diagnostic capabilities, potentially driving increased adoption of MRA for vascular imaging applications.
• Functional information from MR angiography can also guide treatment decisions, contributing to its growing use in clinical practice. Moreover, ongoing research is being conducted to integrate MR guidance into minimally invasive interventions, potentially driving demand for robotic enhancements in specific clinical scenarios.

By End User, Hospitals segment held the largest share of 67.5% in 2023

• Hospitals perform a high volume of interventional procedures, which require advanced imaging technology like robotic angiography systems. The system is essential for performing these procedures, making hospitals the primary market for such technology. Hospitals have access to specialized medical expertise, such as interventional cardiologists, vascular surgeons, and interventional radiologists, who are trained to perform complex procedures using robotic angiography systems.
• Hospitals have larger budgets and greater financial resources, allowing them to make substantial investments in advanced medical equipment. Robotic angiography systems play a crucial role in diagnosing and treating complex cases, attracting patients from surrounding regions. Academic medical centers and teaching hospitals also use robotic angiography systems for research studies, clinical trials, and educational programs. Hospitals must comply with regulatory requirements and accreditation standards related to patient safety, quality of care, and technology standards, incentivizing them to invest in such technology.

Robotic Angiography System Market Regional Insights:

Europe is Expected to Dominate the Market Over the Forecast Period

• Europe is expected to play a significant role in the medical technology market, particularly in robotic angiography systems. This is due to its advanced healthcare infrastructure, technological innovation, strong regulatory environment, universal healthcare coverage, and collaborative approach to healthcare research and innovation. Europe's high-quality healthcare systems, including hospitals, clinics, and medical centers, are conducive to the adoption of robotic angiography systems.
• The European Union's strong regulatory standards ensure patient safety and product quality, facilitating market access for medical devices. Access to healthcare services, such as universal coverage or comprehensive public systems, creates substantial market demand for medical devices and technologies. Europe's collaborative approach to healthcare research and innovation, including public-private partnerships and academic-industry collaborations, accelerates the adoption of robotic angiography systems.
• The increasing cardiovascular disease in Europe, including heart disease and stroke, necessitates advanced diagnostic and treatment modalities like robotic angiography systems. The growing aging population, also drives the adoption of robotic angiography systems, offering precise and minimally invasive options for managing cardiovascular disease.

Robotic Angiography System Market Top Key Players:

• GE Healthcare (US)
• Boston Scientific Corporation (US)
• Abbott Laboratories (US)
• AngioDynamics, Inc. (US)
• Stryker Corporation (US)
• Zimmer Biomet Holdings, Inc. (US)
• Johnson & Johnson (US)
• Cook Medical Inc. (US)
• Merit Medical Systems, Inc. (US)
• Teleflex Incorporated (US)
• Cardinal Health, Inc. (US)
• Siemens Healthineers (Germany)
• B. Braun Melsungen AG (Germany)
• Carl Zeiss Meditec AG (Germany)
• Siemens AG (Germany)
• Smith & Nephew plc (UK)
• Philips Healthcare (Netherlands)
• Medtronic plc (Ireland)
• Terumo Corporation (Japan)
• Canon Medical Systems Corporation (Japan)
• Toshiba Medical Systems Corporation (Japan)
• Shimadzu Corporation (Japan)
• FUJIFILM Holdings Corporation (Japan), and other major players

Key Industry Developments in the Robotic Angiography System Market:

• In February 2024, GE HealthCare, a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, and MedQuest Associates a leading owner, operator, and manager of outpatient diagnostic imaging facilities, announced a three-year collaboration to deliver excellence in patient care by providing access to innovative technologies from GE HealthCare and the infrastructure and resources from MedQuest that are needed to optimize multi-site outpatient imaging networks for success.
• In April 2023, Abbott announced it completed the acquisition of Cardiovascular Systems, Inc. (CSI), a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease. The transaction provides Abbott with a complementary solution for treating vascular disease. CSI's leading atherectomy system prepares vessels for angioplasty or stenting to restore blood flow.
• In June 2022, Siemens Healthineers introduced the angiography system Artis icono ceiling for precise tumor embolization. For super-selective procedures and other complex interventions, Siemens Healthineers developed its new, ceiling-mounted Artis icono ceiling angiography system.

1. INTRODUCTION
   1. RESEARCH OBJECTIVES
   2. RESEARCH METHODOLOGY
   3. RESEARCH PROCESS
   4. SCOPE AND COVERAGE
      1. Market Definition
      2. Key Questions Answered
   5. MARKET SEGMENTATION
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
4. GROWTH OPPORTUNITIES BY SEGMENT
5. MARKET LANDSCAPE
   1. PORTER’S FIVE FORCES ANALYSIS
      1. Bargaining Power Of Supplier
      2. Threat Of New Entrants
      3. Threat Of Substitutes
      4. Competitive Rivalry
      5. Bargaining Power Among Buyers
   2. INDUSTRY VALUE CHAIN ANALYSIS
   3. MARKET DYNAMICS
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
   4. MARKET TREND ANALYSIS
   5. REGULATORY LANDSCAPE
   6. PESTLE ANALYSIS
   7. PRICE TREND ANALYSIS
   8. PATENT ANALYSIS
   9. TECHNOLOGY EVALUATION
   10. MARKET IMPACT OF THE RUSSIA-UKRAINE WAR
       1. Geopolitical Market Disruptions
       2. Supply Chain Disruptions
       3. Instability in Emerging Markets
   11. ECOSYSTEM
6. ROBOTIC ANGIOGRAPHY SYSTEM MARKET BY TYPE (2017-2030)
   1. ROBOTIC ANGIOGRAPHY SYSTEM MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. CT ANGIOGRAPHY SYSTEMS
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2030F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2030F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. X-RAY ANGIOGRAPHY SYSTEMS
   5. MR ANGIOGRAPHY SYSTEMS
7. ROBOTIC ANGIOGRAPHY SYSTEM MARKET BY APPLICATION (2017-2030)
   1. ROBOTIC ANGIOGRAPHY SYSTEM MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. CORONARY ANGIOGRAPHY
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2030F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2030F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. ENDOVASCULAR ANGIOGRAPHY
   5. NEURO-ANGIOGRAPHY
   6. ONCO-ANGIOGRAPHY
8. ROBOTIC ANGIOGRAPHY SYSTEM MARKET BY INDICATION (2017-2030)
   1. ROBOTIC ANGIOGRAPHY SYSTEM MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. CORONARY ARTERY DISEASE
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2030F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2030F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. VALVULAR HEART DISEASE
   5. CONGENITAL HEART DISEASE
   6. CONGESTIVE HEART FAILURE
9. ROBOTIC ANGIOGRAPHY SYSTEM MARKET BY END USER (2017-2030)
   1. ROBOTIC ANGIOGRAPHY SYSTEM MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. SPECIALTY CLINICS
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2030F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2030F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. ACADEMIC AND RESEARCH INSTITUTES
   5. HOSPITALS
   6. DIAGNOSTIC AND IMAGING CENTERS
   7. RESEARCH METHODOLOGY
10. COMPANY PROFILES AND COMPETITIVE ANALYSIS
    1. COMPETITIVE LANDSCAPE
       1. Competitive Positioning
       2. Robotic Angiography System Market Share By Manufacturer (2022)
       3. Industry BCG Matrix
       4. Heat Map Analysis
       5. Mergers & Acquisitions
    2. GE HEALTHCARE (US)
       1. Company Overview
       2. Key Executives
       3. Company Snapshot
       4. Role of the Company in the Market
       5. Sustainability and Social Responsibility
       6. Operating Business Segments
       7. Product Portfolio
       8. Business Performance (Production Volume, Sales Volume, Sales Margin, Production Capacity, Capacity Utilization Rate)
       9. Key Strategic Moves And Recent Developments
       10. SWOT Analysis
    3. BOSTON SCIENTIFIC CORPORATION (US)
    4. ABBOTT LABORATORIES (US)
    5. ANGIODYNAMICS, INC. (US)
    6. STRYKER CORPORATION (US)
    7. STRYKER CORPORATION (US)
    8. ZIMMER BIOMET HOLDINGS, INC. (US)
    9. JOHNSON & JOHNSON (US)
    10. COOK MEDICAL INC. (US)
    11. MERIT MEDICAL SYSTEMS, INC. (US)
    12. TELEFLEX INCORPORATED (US)
    13. CARDINAL HEALTH, INC. (US)
    14. SIEMENS HEALTHINEERS (GERMANY)
    15. B. BRAUN MELSUNGEN AG (GERMANY)
    16. CARL ZEISS MEDITEC AG (GERMANY)
    17. SIEMENS AG (GERMANY)
    18. SMITH & NEPHEW PLC (UK)
    19. PHILIPS HEALTHCARE (NETHERLANDS)
    20. MEDTRONIC PLC (IRELAND)
    21. TERUMO CORPORATION (JAPAN)
    22. CANON MEDICAL SYSTEMS CORPORATION (JAPAN)
    23. TOSHIBA MEDICAL SYSTEMS CORPORATION (JAPAN)
    24. SHIMADZU CORPORATION (JAPAN)
    25. FUJIFILM HOLDINGS CORPORATION (JAPAN)
11. GLOBAL ROBOTIC ANGIOGRAPHY SYSTEM MARKET BY REGION
    1. OVERVIEW
    2. NORTH AMERICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Type
       4. Historic And Forecasted Market Size By Application
       5. Historic And Forecasted Market Size By Indication
       6. Historic And Forecasted Market Size By End User
       7. Historic And Forecasted Market Size By Country
          1. USA
          2. Canada
          3. Mexico
    3. EASTERN EUROPE
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Russia
          2. Bulgaria
          3. The Czech Republic
          4. Hungary
          5. Poland
          6. Romania
          7. Rest Of Eastern Europe
    4. WESTERN EUROPE
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Germany
          2. United Kingdom
          3. France
          4. The Netherlands
          5. Italy
          6. Spain
          7. Rest Of Western Europe
    5. ASIA PACIFIC
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. China
          2. India
          3. Japan
          4. South Korea
          5. Malaysia
          6. Thailand
          7. Vietnam
          8. The Philippines
          9. Australia
          10. New-Zealand
          11. Rest Of APAC
    6. MIDDLE EAST & AFRICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Turkey
          2. Bahrain
          3. Kuwait
          4. Saudi Arabia
          5. Qatar
          6. UAE
          7. Israel
          8. South Africa
    7. SOUTH AMERICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Brazil
          2. Argentina
          3. Rest of South America
12. INVESTMENT ANALYSIS
13. ANALYST VIEWPOINT AND CONCLUSION
    1. Recommendations and Concluding Analysis
    2. Potential Market Strategies

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET COMPETITIVE RIVALRY
TABLE 005. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET THREAT OF NEW ENTRANTS
TABLE 006. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET THREAT OF SUBSTITUTES
TABLE 007. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET BY TECHNOLOGY
TABLE 008. X-RAY ANGIOGRAPHY SYSTEMS MARKET OVERVIEW (2016-2028)
TABLE 009. CT ANGIOGRAPHY SYSTEMS MARKET OVERVIEW (2016-2028)
TABLE 010. MR ANGIOGRAPHY SYSTEMS MARKET OVERVIEW (2016-2028)
TABLE 011. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET BY APPLICATION
TABLE 012. ENDOVASCULAR ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
TABLE 013. ONCO-ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
TABLE 014. CORONARY ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
TABLE 015. NEURO-ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
TABLE 016. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET BY INDICATION
TABLE 017. VALVULAR HEART DISEASE MARKET OVERVIEW (2016-2028)
TABLE 018. CONGESTIVE HEART FAILURE MARKET OVERVIEW (2016-2028)
TABLE 019. CORONARY ARTERY DISEASE MARKET OVERVIEW (2016-2028)
TABLE 020. CONGENITAL HEART DISEASE MARKET OVERVIEW (2016-2028)
TABLE 021. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 022. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET BY END-USER
TABLE 023. SPECIALTY CLINICS MARKET OVERVIEW (2016-2028)
TABLE 024. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 025. DIAGNOSTIC AND IMAGING CENTERS MARKET OVERVIEW (2016-2028)
TABLE 026. ACADEMIC AND RESEARCH INSTITUTES MARKET OVERVIEW (2016-2028)
TABLE 027. NORTH AMERICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY TECHNOLOGY (2016-2028)
TABLE 028. NORTH AMERICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 029. NORTH AMERICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY INDICATION (2016-2028)
TABLE 030. NORTH AMERICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY END-USER (2016-2028)
TABLE 031. N ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 032. EUROPE ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY TECHNOLOGY (2016-2028)
TABLE 033. EUROPE ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 034. EUROPE ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY INDICATION (2016-2028)
TABLE 035. EUROPE ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY END-USER (2016-2028)
TABLE 036. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 037. ASIA PACIFIC ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY TECHNOLOGY (2016-2028)
TABLE 038. ASIA PACIFIC ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 039. ASIA PACIFIC ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY INDICATION (2016-2028)
TABLE 040. ASIA PACIFIC ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY END-USER (2016-2028)
TABLE 041. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 042. MIDDLE EAST & AFRICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY TECHNOLOGY (2016-2028)
TABLE 043. MIDDLE EAST & AFRICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 044. MIDDLE EAST & AFRICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY INDICATION (2016-2028)
TABLE 045. MIDDLE EAST & AFRICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY END-USER (2016-2028)
TABLE 046. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 047. SOUTH AMERICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY TECHNOLOGY (2016-2028)
TABLE 048. SOUTH AMERICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 049. SOUTH AMERICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY INDICATION (2016-2028)
TABLE 050. SOUTH AMERICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY END-USER (2016-2028)
TABLE 051. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 052. GE HEALTHCARE (US): SNAPSHOT
TABLE 053. GE HEALTHCARE (US): BUSINESS PERFORMANCE
TABLE 054. GE HEALTHCARE (US): PRODUCT PORTFOLIO
TABLE 055. GE HEALTHCARE (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. KUKA (GERMANY): SNAPSHOT
TABLE 056. KUKA (GERMANY): BUSINESS PERFORMANCE
TABLE 057. KUKA (GERMANY): PRODUCT PORTFOLIO
TABLE 058. KUKA (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. SIEMENS HEALTHCARE PRIVATE LIMITED (GERMANY): SNAPSHOT
TABLE 059. SIEMENS HEALTHCARE PRIVATE LIMITED (GERMANY): BUSINESS PERFORMANCE
TABLE 060. SIEMENS HEALTHCARE PRIVATE LIMITED (GERMANY): PRODUCT PORTFOLIO
TABLE 061. SIEMENS HEALTHCARE PRIVATE LIMITED (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. CORINDUS INC.: SNAPSHOT
TABLE 062. CORINDUS INC.: BUSINESS PERFORMANCE
TABLE 063. CORINDUS INC.: PRODUCT PORTFOLIO
TABLE 064. CORINDUS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. PHILIPS HEALTHCARE (NETHERLANDS): SNAPSHOT
TABLE 065. PHILIPS HEALTHCARE (NETHERLANDS): BUSINESS PERFORMANCE
TABLE 066. PHILIPS HEALTHCARE (NETHERLANDS): PRODUCT PORTFOLIO
TABLE 067. PHILIPS HEALTHCARE (NETHERLANDS): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. ABBOTT (US): SNAPSHOT
TABLE 068. ABBOTT (US): BUSINESS PERFORMANCE
TABLE 069. ABBOTT (US): PRODUCT PORTFOLIO
TABLE 070. ABBOTT (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. SHIMADZU MEDICAL SYSTEMS (JAPAN): SNAPSHOT
TABLE 071. SHIMADZU MEDICAL SYSTEMS (JAPAN): BUSINESS PERFORMANCE
TABLE 072. SHIMADZU MEDICAL SYSTEMS (JAPAN): PRODUCT PORTFOLIO
TABLE 073. SHIMADZU MEDICAL SYSTEMS (JAPAN): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. CANON MEDICAL SYSTEMS CORPORATION (JAPAN): SNAPSHOT
TABLE 074. CANON MEDICAL SYSTEMS CORPORATION (JAPAN): BUSINESS PERFORMANCE
TABLE 075. CANON MEDICAL SYSTEMS CORPORATION (JAPAN): PRODUCT PORTFOLIO
TABLE 076. CANON MEDICAL SYSTEMS CORPORATION (JAPAN): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 076. BOSTON SCIENTIFIC CORPORATION (US): SNAPSHOT
TABLE 077. BOSTON SCIENTIFIC CORPORATION (US): BUSINESS PERFORMANCE
TABLE 078. BOSTON SCIENTIFIC CORPORATION (US): PRODUCT PORTFOLIO
TABLE 079. BOSTON SCIENTIFIC CORPORATION (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 079. ANGIODYNAMICS (US): SNAPSHOT
TABLE 080. ANGIODYNAMICS (US): BUSINESS PERFORMANCE
TABLE 081. ANGIODYNAMICS (US): PRODUCT PORTFOLIO
TABLE 082. ANGIODYNAMICS (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 082. MEDTRONIC PLC (IRELAND): SNAPSHOT
TABLE 083. MEDTRONIC PLC (IRELAND): BUSINESS PERFORMANCE
TABLE 084. MEDTRONIC PLC (IRELAND): PRODUCT PORTFOLIO
TABLE 085. MEDTRONIC PLC (IRELAND): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 085. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 086. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 087. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 088. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET OVERVIEW BY TECHNOLOGY
FIGURE 012. X-RAY ANGIOGRAPHY SYSTEMS MARKET OVERVIEW (2016-2028)
FIGURE 013. CT ANGIOGRAPHY SYSTEMS MARKET OVERVIEW (2016-2028)
FIGURE 014. MR ANGIOGRAPHY SYSTEMS MARKET OVERVIEW (2016-2028)
FIGURE 015. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET OVERVIEW BY APPLICATION
FIGURE 016. ENDOVASCULAR ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
FIGURE 017. ONCO-ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
FIGURE 018. CORONARY ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
FIGURE 019. NEURO-ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
FIGURE 020. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET OVERVIEW BY INDICATION
FIGURE 021. VALVULAR HEART DISEASE MARKET OVERVIEW (2016-2028)
FIGURE 022. CONGESTIVE HEART FAILURE MARKET OVERVIEW (2016-2028)
FIGURE 023. CORONARY ARTERY DISEASE MARKET OVERVIEW (2016-2028)
FIGURE 024. CONGENITAL HEART DISEASE MARKET OVERVIEW (2016-2028)
FIGURE 025. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 026. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET OVERVIEW BY END-USER
FIGURE 027. SPECIALTY CLINICS MARKET OVERVIEW (2016-2028)
FIGURE 028. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 029. DIAGNOSTIC AND IMAGING CENTERS MARKET OVERVIEW (2016-2028)
FIGURE 030. ACADEMIC AND RESEARCH INSTITUTES MARKET OVERVIEW (2016-2028)
FIGURE 031. NORTH AMERICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 032. EUROPE ROBOTIC ANGIOGRAPHY SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 033. ASIA PACIFIC ROBOTIC ANGIOGRAPHY SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 034. MIDDLE EAST & AFRICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 035. SOUTH AMERICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)